After addition of blank medium, free vinorelbine, vinorelbine lipid vesicles, or CNP-modified vinorelbine lipid vesicles, ROS activity in glioma cells was 1.00±0.37, 2.81±0.78, 3.95±0.92, and 7.76±0.74, respectively. This evidence concerns the gene CNP and central nervous system cancer.